In the last trading session, 1,877,571 shares of the FibroGen, Inc. (NASDAQ:FGEN) were traded, and its beta was 1.19. Most recently the company’s share price was $34.64, and it changed around -$0.99 or -0.03% from the last close, which brings the market valuation of the company to $3.17 Billion. FGEN currently trades at a discount to its 52-week high of $57.21, offering almost -65.16% off that amount. The share price’s 52-week low was $30.77, which indicates that the current value has risen by an impressive 11.17% since then. We note from FibroGen, Inc.’s average daily trading volume that its 10-day average is 988.48 Million shares, with the 3-month average coming to 964.2 Million.
FibroGen, Inc. stock received a consensus recommendation rating of Overweight, based on a mean score of 2.3. If we narrow it down even further, the data shows that 1 out of 10 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, 4 recommended FGEN as a Hold, whereas 5 deemed it a Buy, and no one rated it as Underweight. FibroGen, Inc. is expected to report earnings per share of -$0.7 for the current quarter.
FibroGen, Inc. (NASDAQ:FGEN): Trading Information
Although FGEN has showed a red trend with a performance of -2.78% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of $36.13 on Thursday, Apr 01 increased the stock’s daily price by 4.11%. The company’s shares are currently down -0.07% year-to-date, but still up 0.1174 over the last five days. On the other hand, FibroGen, Inc. (NASDAQ:FGEN) is -0.03% down in the 30-day period. We can see from the shorts that 8.51 Million shares have been sold at a short interest cover period of 0.01 day (s).
The consensus price target as assigned by Wall Street analysts is $54.75, which translates to bears needing to increase their stock price by 58.05% from its current value. Analyst projections state that FGEN is forecast to be at a low of $44 and a high of $72. In order for the stock price to hit the forecast high, the stock would need to surge +107.85% from its current level, while the stock would need to crash 27.02% from its current level to reach the projected low.
FibroGen, Inc. (FGEN) projections and forecasts
FibroGen, Inc. share prices are not performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -16.25 percent over the past six months and at a -28.91% annual growth rate that is well below the industry average of 17.3%. Moreover, analysts have decided to roll up on their fiscal year 2021 revenue estimates. The rating firms predict that it will gain +21.3% in revenue this quarter, and will report an increase of 45.3% in the next quarter. The year-over-year growth rate is expected to be 137.5%, up from the previous year.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.2%. FibroGen, Inc. earnings are expected to decrease by -137.1% in 2021, but the outlook is negative 0% per year for the next five years.
FibroGen, Inc. (NASDAQ:FGEN)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 8.03% of FibroGen, Inc. shares, and 79.96% of them are in the hands of institutional investors. The stock currently has a share float of 86.93%. FibroGen, Inc. stock is held by 313 institutions, with Primecap Management Company being the largest institutional investor. By Dec 30, 2020, it held 10.08% of the shares, which is about 9.23 Million shares worth $342.27 Million.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Blackrock Inc., with 8.63% or 7.9 Million shares worth $292.92 Million as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
Primecap Odyssey Aggressive Growth Fund and Vanguard Horizon Fund-Capital Opportunity Portfolio were the top two Mutual Funds as of Jan 30, 2021. The former held 3374631 shares worth $162.59 Million, making up 3.69% of all outstanding shares. On the other hand, Vanguard Horizon Fund-Capital Opportunity Portfolio held roughly 2.53 Million shares worth around $93.87 Million, which represents about 2.76% of the total shares outstanding.